img

Global Hormonal Drugs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hormonal Drugs Market Insights, Forecast to 2034

Hormone drugs are drugs that use human or animal hormones (including organic substances with the same structure and action principle as hormones) as active ingredients.
Global Hormonal Drugs market is expected to reach to US$ 112.8 million in 2024, with a positive growth of %, compared with US$ 955.8 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Hormonal Drugs industry is evaluated to reach US$ 220.2 million in 2029. The CAGR will be 11.8% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Hormonal Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Hormonal Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Roche
Novartis
Mitsubishi Tanabe Pharma Korea
Anhui Renhe Pharmaceutical
Shanghai ZhongHua Pharmaceutical Nantong
He'nan Xuchang Huaren Pharmaceutical
Wuhan Wujing Pharmaceutical
Harbin Pharmaceutical Group
Changzhou Siyao Pharmaceuticals
Hunan Wzt Pharmaceutical
Tianjin Tianyao Pharmaceutical
Henan Lihua Pharmaceutical
Hubei Tiansheng Pharmaceutica
Shandong Xinhua Pharmaceutical
Huazhong Pharmaceutical
China Resources Zizhu Pharmaceutical
Shanghai CP GENERAL Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Segment by Type
Intravenous Injection
Take Orally
Topical
Others

Segment by Application


Hospital
Pharmacy
Clinic

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Hormonal Drugs plant distribution, commercial date of Hormonal Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Hormonal Drugs introduction, etc. Hormonal Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Hormonal Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Hormonal Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Hormonal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Intravenous Injection
1.2.3 Take Orally
1.2.4 Topical
1.2.5 Others
1.3 Market by Application
1.3.1 Global Hormonal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hormonal Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Hormonal Drugs Revenue by Region
2.2.1 Global Hormonal Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Hormonal Drugs Revenue by Region (2018-2024)
2.2.3 Global Hormonal Drugs Revenue by Region (2024-2029)
2.2.4 Global Hormonal Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Hormonal Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Hormonal Drugs Sales by Region
2.4.1 Global Hormonal Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Hormonal Drugs Sales by Region (2018-2024)
2.4.3 Global Hormonal Drugs Sales by Region (2024-2029)
2.4.4 Global Hormonal Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Hormonal Drugs Sales by Manufacturers
3.1.1 Global Hormonal Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Hormonal Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hormonal Drugs in 2022
3.2 Global Hormonal Drugs Revenue by Manufacturers
3.2.1 Global Hormonal Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Hormonal Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Hormonal Drugs Revenue in 2022
3.3 Global Key Players of Hormonal Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Hormonal Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Hormonal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Hormonal Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Hormonal Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Hormonal Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hormonal Drugs Sales by Type
4.1.1 Global Hormonal Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Hormonal Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Hormonal Drugs Sales Market Share by Type (2018-2029)
4.2 Global Hormonal Drugs Revenue by Type
4.2.1 Global Hormonal Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Hormonal Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Hormonal Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Hormonal Drugs Price by Type
4.3.1 Global Hormonal Drugs Price by Type (2018-2024)
4.3.2 Global Hormonal Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Hormonal Drugs Sales by Application
5.1.1 Global Hormonal Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Hormonal Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Hormonal Drugs Sales Market Share by Application (2018-2029)
5.2 Global Hormonal Drugs Revenue by Application
5.2.1 Global Hormonal Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Hormonal Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Hormonal Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Hormonal Drugs Price by Application
5.3.1 Global Hormonal Drugs Price by Application (2018-2024)
5.3.2 Global Hormonal Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Hormonal Drugs Market Size by Type
6.1.1 US & Canada Hormonal Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Hormonal Drugs Revenue by Type (2018-2029)
6.2 US & Canada Hormonal Drugs Market Size by Application
6.2.1 US & Canada Hormonal Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Hormonal Drugs Revenue by Application (2018-2029)
6.3 US & Canada Hormonal Drugs Market Size by Country
6.3.1 US & Canada Hormonal Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Hormonal Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Hormonal Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Hormonal Drugs Market Size by Type
7.1.1 Europe Hormonal Drugs Sales by Type (2018-2029)
7.1.2 Europe Hormonal Drugs Revenue by Type (2018-2029)
7.2 Europe Hormonal Drugs Market Size by Application
7.2.1 Europe Hormonal Drugs Sales by Application (2018-2029)
7.2.2 Europe Hormonal Drugs Revenue by Application (2018-2029)
7.3 Europe Hormonal Drugs Market Size by Country
7.3.1 Europe Hormonal Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Hormonal Drugs Sales by Country (2018-2029)
7.3.3 Europe Hormonal Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Hormonal Drugs Market Size
8.1.1 China Hormonal Drugs Sales (2018-2029)
8.1.2 China Hormonal Drugs Revenue (2018-2029)
8.2 China Hormonal Drugs Market Size by Application
8.2.1 China Hormonal Drugs Sales by Application (2018-2029)
8.2.2 China Hormonal Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Hormonal Drugs Market Size by Type
9.1.1 Asia Hormonal Drugs Sales by Type (2018-2029)
9.1.2 Asia Hormonal Drugs Revenue by Type (2018-2029)
9.2 Asia Hormonal Drugs Market Size by Application
9.2.1 Asia Hormonal Drugs Sales by Application (2018-2029)
9.2.2 Asia Hormonal Drugs Revenue by Application (2018-2029)
9.3 Asia Hormonal Drugs Sales by Region
9.3.1 Asia Hormonal Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Hormonal Drugs Revenue by Region (2018-2029)
9.3.3 Asia Hormonal Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Hormonal Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Hormonal Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Hormonal Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Hormonal Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Hormonal Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Hormonal Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Hormonal Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Hormonal Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Hormonal Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Hormonal Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merck Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Overview
11.2.3 Roche Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Roche Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novartis Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Mitsubishi Tanabe Pharma Korea
11.4.1 Mitsubishi Tanabe Pharma Korea Company Information
11.4.2 Mitsubishi Tanabe Pharma Korea Overview
11.4.3 Mitsubishi Tanabe Pharma Korea Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Mitsubishi Tanabe Pharma Korea Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mitsubishi Tanabe Pharma Korea Recent Developments
11.5 Anhui Renhe Pharmaceutical
11.5.1 Anhui Renhe Pharmaceutical Company Information
11.5.2 Anhui Renhe Pharmaceutical Overview
11.5.3 Anhui Renhe Pharmaceutical Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Anhui Renhe Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Anhui Renhe Pharmaceutical Recent Developments
11.6 Shanghai ZhongHua Pharmaceutical Nantong
11.6.1 Shanghai ZhongHua Pharmaceutical Nantong Company Information
11.6.2 Shanghai ZhongHua Pharmaceutical Nantong Overview
11.6.3 Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shanghai ZhongHua Pharmaceutical Nantong Recent Developments
11.7 He'nan Xuchang Huaren Pharmaceutical
11.7.1 He'nan Xuchang Huaren Pharmaceutical Company Information
11.7.2 He'nan Xuchang Huaren Pharmaceutical Overview
11.7.3 He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 He'nan Xuchang Huaren Pharmaceutical Recent Developments
11.8 Wuhan Wujing Pharmaceutical
11.8.1 Wuhan Wujing Pharmaceutical Company Information
11.8.2 Wuhan Wujing Pharmaceutical Overview
11.8.3 Wuhan Wujing Pharmaceutical Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Wuhan Wujing Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wuhan Wujing Pharmaceutical Recent Developments
11.9 Harbin Pharmaceutical Group
11.9.1 Harbin Pharmaceutical Group Company Information
11.9.2 Harbin Pharmaceutical Group Overview
11.9.3 Harbin Pharmaceutical Group Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Harbin Pharmaceutical Group Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Harbin Pharmaceutical Group Recent Developments
11.10 Changzhou Siyao Pharmaceuticals
11.10.1 Changzhou Siyao Pharmaceuticals Company Information
11.10.2 Changzhou Siyao Pharmaceuticals Overview
11.10.3 Changzhou Siyao Pharmaceuticals Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Changzhou Siyao Pharmaceuticals Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Changzhou Siyao Pharmaceuticals Recent Developments
11.11 Hunan Wzt Pharmaceutical
11.11.1 Hunan Wzt Pharmaceutical Company Information
11.11.2 Hunan Wzt Pharmaceutical Overview
11.11.3 Hunan Wzt Pharmaceutical Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Hunan Wzt Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hunan Wzt Pharmaceutical Recent Developments
11.12 Tianjin Tianyao Pharmaceutical
11.12.1 Tianjin Tianyao Pharmaceutical Company Information
11.12.2 Tianjin Tianyao Pharmaceutical Overview
11.12.3 Tianjin Tianyao Pharmaceutical Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Tianjin Tianyao Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Tianjin Tianyao Pharmaceutical Recent Developments
11.13 Henan Lihua Pharmaceutical
11.13.1 Henan Lihua Pharmaceutical Company Information
11.13.2 Henan Lihua Pharmaceutical Overview
11.13.3 Henan Lihua Pharmaceutical Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Henan Lihua Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Henan Lihua Pharmaceutical Recent Developments
11.14 Hubei Tiansheng Pharmaceutica
11.14.1 Hubei Tiansheng Pharmaceutica Company Information
11.14.2 Hubei Tiansheng Pharmaceutica Overview
11.14.3 Hubei Tiansheng Pharmaceutica Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Hubei Tiansheng Pharmaceutica Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Hubei Tiansheng Pharmaceutica Recent Developments
11.15 Shandong Xinhua Pharmaceutical
11.15.1 Shandong Xinhua Pharmaceutical Company Information
11.15.2 Shandong Xinhua Pharmaceutical Overview
11.15.3 Shandong Xinhua Pharmaceutical Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Shandong Xinhua Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Shandong Xinhua Pharmaceutical Recent Developments
11.16 Huazhong Pharmaceutical
11.16.1 Huazhong Pharmaceutical Company Information
11.16.2 Huazhong Pharmaceutical Overview
11.16.3 Huazhong Pharmaceutical Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Huazhong Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Huazhong Pharmaceutical Recent Developments
11.17 China Resources Zizhu Pharmaceutical
11.17.1 China Resources Zizhu Pharmaceutical Company Information
11.17.2 China Resources Zizhu Pharmaceutical Overview
11.17.3 China Resources Zizhu Pharmaceutical Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 China Resources Zizhu Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 China Resources Zizhu Pharmaceutical Recent Developments
11.18 Shanghai CP GENERAL Pharmaceutical
11.18.1 Shanghai CP GENERAL Pharmaceutical Company Information
11.18.2 Shanghai CP GENERAL Pharmaceutical Overview
11.18.3 Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Shanghai CP GENERAL Pharmaceutical Recent Developments
11.19 Jiangsu Lianhuan Pharmaceutical
11.19.1 Jiangsu Lianhuan Pharmaceutical Company Information
11.19.2 Jiangsu Lianhuan Pharmaceutical Overview
11.19.3 Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Jiangsu Lianhuan Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hormonal Drugs Industry Chain Analysis
12.2 Hormonal Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hormonal Drugs Production Mode & Process
12.4 Hormonal Drugs Sales and Marketing
12.4.1 Hormonal Drugs Sales Channels
12.4.2 Hormonal Drugs Distributors
12.5 Hormonal Drugs Customers
13 Market Dynamics
13.1 Hormonal Drugs Industry Trends
13.2 Hormonal Drugs Market Drivers
13.3 Hormonal Drugs Market Challenges
13.4 Hormonal Drugs Market Restraints
14 Key Findings in The Global Hormonal Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Hormonal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Intravenous Injection
Table 3. Major Manufacturers of Take Orally
Table 4. Major Manufacturers of Topical
Table 5. Major Manufacturers of Others
Table 6. Global Hormonal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Hormonal Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Hormonal Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Hormonal Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Hormonal Drugs Revenue Market Share by Region (2018-2024)
Table 11. Global Hormonal Drugs Revenue Market Share by Region (2024-2029)
Table 12. Global Hormonal Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Hormonal Drugs Sales by Region (2018-2024) & (K Units)
Table 14. Global Hormonal Drugs Sales by Region (2024-2029) & (K Units)
Table 15. Global Hormonal Drugs Sales Market Share by Region (2018-2024)
Table 16. Global Hormonal Drugs Sales Market Share by Region (2024-2029)
Table 17. Global Hormonal Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Hormonal Drugs Sales Share by Manufacturers (2018-2024)
Table 19. Global Hormonal Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Hormonal Drugs Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Hormonal Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Hormonal Drugs Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Hormonal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Hormonal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Drugs as of 2022)
Table 25. Global Key Manufacturers of Hormonal Drugs, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Hormonal Drugs, Product Offered and Application
Table 27. Global Key Manufacturers of Hormonal Drugs, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Hormonal Drugs Sales by Type (2018-2024) & (K Units)
Table 30. Global Hormonal Drugs Sales by Type (2024-2029) & (K Units)
Table 31. Global Hormonal Drugs Sales Share by Type (2018-2024)
Table 32. Global Hormonal Drugs Sales Share by Type (2024-2029)
Table 33. Global Hormonal Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Hormonal Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Hormonal Drugs Revenue Share by Type (2018-2024)
Table 36. Global Hormonal Drugs Revenue Share by Type (2024-2029)
Table 37. Hormonal Drugs Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Hormonal Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Hormonal Drugs Sales by Application (2018-2024) & (K Units)
Table 40. Global Hormonal Drugs Sales by Application (2024-2029) & (K Units)
Table 41. Global Hormonal Drugs Sales Share by Application (2018-2024)
Table 42. Global Hormonal Drugs Sales Share by Application (2024-2029)
Table 43. Global Hormonal Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Hormonal Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Hormonal Drugs Revenue Share by Application (2018-2024)
Table 46. Global Hormonal Drugs Revenue Share by Application (2024-2029)
Table 47. Hormonal Drugs Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Hormonal Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Hormonal Drugs Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Hormonal Drugs Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Hormonal Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Hormonal Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Hormonal Drugs Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Hormonal Drugs Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Hormonal Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Hormonal Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Hormonal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Hormonal Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Hormonal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Hormonal Drugs Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Hormonal Drugs Sales by Country (2024-2029) & (K Units)
Table 62. Europe Hormonal Drugs Sales by Type (2018-2024) & (K Units)
Table 63. Europe Hormonal Drugs Sales by Type (2024-2029) & (K Units)
Table 64. Europe Hormonal Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Hormonal Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Hormonal Drugs Sales by Application (2018-2024) & (K Units)
Table 67. Europe Hormonal Drugs Sales by Application (2024-2029) & (K Units)
Table 68. Europe Hormonal Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Hormonal Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Hormonal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Hormonal Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Hormonal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Hormonal Drugs Sales by Country (2018-2024) & (K Units)
Table 74. Europe Hormonal Drugs Sales by Country (2024-2029) & (K Units)
Table 75. China Hormonal Drugs Sales by Type (2018-2024) & (K Units)
Table 76. China Hormonal Drugs Sales by Type (2024-2029) & (K Units)
Table 77. China Hormonal Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Hormonal Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Hormonal Drugs Sales by Application (2018-2024) & (K Units)
Table 80. China Hormonal Drugs Sales by Application (2024-2029) & (K Units)
Table 81. China Hormonal Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Hormonal Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Hormonal Drugs Sales by Type (2018-2024) & (K Units)
Table 84. Asia Hormonal Drugs Sales by Type (2024-2029) & (K Units)
Table 85. Asia Hormonal Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Hormonal Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Hormonal Drugs Sales by Application (2018-2024) & (K Units)
Table 88. Asia Hormonal Drugs Sales by Application (2024-2029) & (K Units)
Table 89. Asia Hormonal Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Hormonal Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Hormonal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Hormonal Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Hormonal Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Hormonal Drugs Sales by Region (2018-2024) & (K Units)
Table 95. Asia Hormonal Drugs Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Hormonal Drugs Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Hormonal Drugs Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Hormonal Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Hormonal Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Hormonal Drugs Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Hormonal Drugs Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Hormonal Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Hormonal Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Hormonal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Hormonal Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Hormonal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Hormonal Drugs Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Hormonal Drugs Sales by Country (2024-2029) & (K Units)
Table 109. Merck Company Information
Table 110. Merck Description and Major Businesses
Table 111. Merck Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Merck Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Merck Recent Developments
Table 114. Roche Company Information
Table 115. Roche Description and Major Businesses
Table 116. Roche Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Roche Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Roche Recent Developments
Table 119. Novartis Company Information
Table 120. Novartis Description and Major Businesses
Table 121. Novartis Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Novartis Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Novartis Recent Developments
Table 124. Mitsubishi Tanabe Pharma Korea Company Information
Table 125. Mitsubishi Tanabe Pharma Korea Description and Major Businesses
Table 126. Mitsubishi Tanabe Pharma Korea Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Mitsubishi Tanabe Pharma Korea Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Mitsubishi Tanabe Pharma Korea Recent Developments
Table 129. Anhui Renhe Pharmaceutical Company Information
Table 130. Anhui Renhe Pharmaceutical Description and Major Businesses
Table 131. Anhui Renhe Pharmaceutical Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Anhui Renhe Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Anhui Renhe Pharmaceutical Recent Developments
Table 134. Shanghai ZhongHua Pharmaceutical Nantong Company Information
Table 135. Shanghai ZhongHua Pharmaceutical Nantong Description and Major Businesses
Table 136. Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Shanghai ZhongHua Pharmaceutical Nantong Recent Developments
Table 139. He'nan Xuchang Huaren Pharmaceutical Company Information
Table 140. He'nan Xuchang Huaren Pharmaceutical Description and Major Businesses
Table 141. He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. He'nan Xuchang Huaren Pharmaceutical Recent Developments
Table 144. Wuhan Wujing Pharmaceutical Company Information
Table 145. Wuhan Wujing Pharmaceutical Description and Major Businesses
Table 146. Wuhan Wujing Pharmaceutical Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Wuhan Wujing Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Wuhan Wujing Pharmaceutical Recent Developments
Table 149. Harbin Pharmaceutical Group Company Information
Table 150. Harbin Pharmaceutical Group Description and Major Businesses
Table 151. Harbin Pharmaceutical Group Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Harbin Pharmaceutical Group Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Harbin Pharmaceutical Group Recent Developments
Table 154. Changzhou Siyao Pharmaceuticals Company Information
Table 155. Changzhou Siyao Pharmaceuticals Description and Major Businesses
Table 156. Changzhou Siyao Pharmaceuticals Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Changzhou Siyao Pharmaceuticals Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Changzhou Siyao Pharmaceuticals Recent Developments
Table 159. Hunan Wzt Pharmaceutical Company Information
Table 160. Hunan Wzt Pharmaceutical Description and Major Businesses
Table 161. Hunan Wzt Pharmaceutical Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Hunan Wzt Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Hunan Wzt Pharmaceutical Recent Developments
Table 164. Tianjin Tianyao Pharmaceutical Company Information
Table 165. Tianjin Tianyao Pharmaceutical Description and Major Businesses
Table 166. Tianjin Tianyao Pharmaceutical Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Tianjin Tianyao Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Tianjin Tianyao Pharmaceutical Recent Developments
Table 169. Henan Lihua Pharmaceutical Company Information
Table 170. Henan Lihua Pharmaceutical Description and Major Businesses
Table 171. Henan Lihua Pharmaceutical Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Henan Lihua Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Henan Lihua Pharmaceutical Recent Developments
Table 174. Hubei Tiansheng Pharmaceutica Company Information
Table 175. Hubei Tiansheng Pharmaceutica Description and Major Businesses
Table 176. Hubei Tiansheng Pharmaceutica Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Hubei Tiansheng Pharmaceutica Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Hubei Tiansheng Pharmaceutica Recent Developments
Table 179. Shandong Xinhua Pharmaceutical Company Information
Table 180. Shandong Xinhua Pharmaceutical Description and Major Businesses
Table 181. Shandong Xinhua Pharmaceutical Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Shandong Xinhua Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Shandong Xinhua Pharmaceutical Recent Developments
Table 184. Huazhong Pharmaceutical Company Information
Table 185. Huazhong Pharmaceutical Description and Major Businesses
Table 186. Huazhong Pharmaceutical Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. Huazhong Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Huazhong Pharmaceutical Recent Developments
Table 189. China Resources Zizhu Pharmaceutical Company Information
Table 190. China Resources Zizhu Pharmaceutical Description and Major Businesses
Table 191. China Resources Zizhu Pharmaceutical Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 192. China Resources Zizhu Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. China Resources Zizhu Pharmaceutical Recent Developments
Table 194. Shanghai CP GENERAL Pharmaceutical Company Information
Table 195. Shanghai CP GENERAL Pharmaceutical Description and Major Businesses
Table 196. Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 197. Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. Shanghai CP GENERAL Pharmaceutical Recent Developments
Table 199. Jiangsu Lianhuan Pharmaceutical Company Information
Table 200. Jiangsu Lianhuan Pharmaceutical Description and Major Businesses
Table 201. Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 202. Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 203. Jiangsu Lianhuan Pharmaceutical Recent Developments
Table 204. Key Raw Materials Lists
Table 205. Raw Materials Key Suppliers Lists
Table 206. Hormonal Drugs Distributors List
Table 207. Hormonal Drugs Customers List
Table 208. Hormonal Drugs Market Trends
Table 209. Hormonal Drugs Market Drivers
Table 210. Hormonal Drugs Market Challenges
Table 211. Hormonal Drugs Market Restraints
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Hormonal Drugs Product Picture
Figure 2. Global Hormonal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Hormonal Drugs Market Share by Type in 2022 & 2029
Figure 4. Intravenous Injection Product Picture
Figure 5. Take Orally Product Picture
Figure 6. Topical Product Picture
Figure 7. Others Product Picture
Figure 8. Global Hormonal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Hormonal Drugs Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Pharmacy
Figure 12. Clinic
Figure 13. Hormonal Drugs Report Years Considered
Figure 14. Global Hormonal Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Hormonal Drugs Revenue 2018-2029 (US$ Million)
Figure 16. Global Hormonal Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Hormonal Drugs Revenue Market Share by Region (2018-2029)
Figure 18. Global Hormonal Drugs Sales 2018-2029 ((K Units)
Figure 19. Global Hormonal Drugs Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Hormonal Drugs Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Hormonal Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Hormonal Drugs Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Hormonal Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Hormonal Drugs Sales YoY (2018-2029) & (K Units)
Figure 25. China Hormonal Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Hormonal Drugs Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Hormonal Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Hormonal Drugs Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Hormonal Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Hormonal Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Hormonal Drugs in the World: Market Share by Hormonal Drugs Revenue in 2022
Figure 32. Global Hormonal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Hormonal Drugs Sales Market Share by Type (2018-2029)
Figure 34. Global Hormonal Drugs Revenue Market Share by Type (2018-2029)
Figure 35. Global Hormonal Drugs Sales Market Share by Application (2018-2029)
Figure 36. Global Hormonal Drugs Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Hormonal Drugs Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Hormonal Drugs Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Hormonal Drugs Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Hormonal Drugs Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Hormonal Drugs Revenue Share by Country (2018-2029)
Figure 42. US & Canada Hormonal Drugs Sales Share by Country (2018-2029)
Figure 43. U.S. Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Hormonal Drugs Sales Market Share by Type (2018-2029)
Figure 46. Europe Hormonal Drugs Revenue Market Share by Type (2018-2029)
Figure 47. Europe Hormonal Drugs Sales Market Share by Application (2018-2029)
Figure 48. Europe Hormonal Drugs Revenue Market Share by Application (2018-2029)
Figure 49. Europe Hormonal Drugs Revenue Share by Country (2018-2029)
Figure 50. Europe Hormonal Drugs Sales Share by Country (2018-2029)
Figure 51. Germany Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. France Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. China Hormonal Drugs Sales Market Share by Type (2018-2029)
Figure 57. China Hormonal Drugs Revenue Market Share by Type (2018-2029)
Figure 58. China Hormonal Drugs Sales Market Share by Application (2018-2029)
Figure 59. China Hormonal Drugs Revenue Market Share by Application (2018-2029)
Figure 60. Asia Hormonal Drugs Sales Market Share by Type (2018-2029)
Figure 61. Asia Hormonal Drugs Revenue Market Share by Type (2018-2029)
Figure 62. Asia Hormonal Drugs Sales Market Share by Application (2018-2029)
Figure 63. Asia Hormonal Drugs Revenue Market Share by Application (2018-2029)
Figure 64. Asia Hormonal Drugs Revenue Share by Region (2018-2029)
Figure 65. Asia Hormonal Drugs Sales Share by Region (2018-2029)
Figure 66. Japan Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. India Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Hormonal Drugs Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Hormonal Drugs Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Hormonal Drugs Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Hormonal Drugs Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Hormonal Drugs Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Hormonal Drugs Sales Share by Country (2018-2029)
Figure 77. Brazil Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Hormonal Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. Hormonal Drugs Value Chain
Figure 83. Hormonal Drugs Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed